Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence

被引:73
作者
Shalitin, S.
Phillip, M.
Stein, J.
Goshen, Y.
Carmi, D.
Yaniv, I.
机构
[1] Schneider Childrens Med Ctr Israel, Natl Ctr Childhood Diabet, Inst Endocrinol & Diabet, IL-49202 Petah Tiqwa, Israel
[2] Schneider Childrens Med Ctr Israel, Dept Hematol Oncol, Bone Marrow Transplantat Unit, IL-49202 Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
growth; thyroid gland; hypogonadism; diabetes;
D O I
10.1038/sj.bmt.1705374
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Endocrine dysfunction and parameters of metabolic syndrome were assessed in 91 patients aged 4.3-32.5 years who underwent allogeneic or autologous BMT in childhood. Final short stature, found in five of the 35 patients who attained final height, was associated with the underlying disease (specifically, Fanconi anemia) (P=0.0013), previous cranial irradiation (P=0.0007), type of conditioning irradiation (P < 0.05) and allogeneic BMT (P=0.05). Growth hormone deficiency (n=10) was associated with previous cranial irradiation (P < 0.005) and conditioning total body irradiation (P < 0.001). Twelve patients had primary hypothyroidism, one had hyperthyroidism and one papillary thyroid carcinoma. Hypothyroidism was associated with neck/mediastinal (P < 0.005) and conditioning irradiation (P < 0.05). Primary gonadal failure was found in 24 of the mature patients (62.5% females). Hypogonadism was associated with the underlying disease (especially hematological malignancies) (P < 0.05), pretransplant treatment (P < 0.05), irradiation conditioning (P < 0.001), older age (P < 0.005) and advanced pubertal stage at BMT (P < 0.05). Obesity (body mass index > 2 s.d.) was found in 4.4% and type II diabetes and impaired glucose tolerance in 3.3% each. Dyslipidemia was found in 27.9% of the 43 patients tested. These findings emphasize the need for long-term follow-up of endocrine and metabolic parameters in young patients after BMT in order to offer proper treatment and improve quality of life.
引用
收藏
页码:1109 / 1117
页数:9
相关论文
共 42 条
[1]   Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide [J].
Afify, Z ;
Shaw, PJ ;
Clavano-Harding, A ;
Cowell, CT .
BONE MARROW TRANSPLANTATION, 2000, 25 (10) :1087-1092
[2]  
[Anonymous], 2000, CDC GROWTH CHARTS US
[3]  
Ariza-Andraca CR, 1998, ARCH MED RES, V29, P259
[4]   Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation [J].
Au, WY ;
Lie, AKW ;
Kung, AWC ;
Liang, R ;
Hawkins, BR ;
Kwong, YL .
BONE MARROW TRANSPLANTATION, 2005, 35 (04) :383-388
[5]   Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood [J].
Bakker, B ;
Oostdijk, W ;
Bresters, D ;
Walenkamp, MJE ;
Vossen, JM ;
Wit, JM .
BONE MARROW TRANSPLANTATION, 2004, 33 (10) :1049-1056
[6]  
BORGSTROM B, 1994, BONE MARROW TRANSPL, V13, P59
[7]  
BOULAD F, 1995, BONE MARROW TRANSPL, V15, P71
[8]   A PROSPECTIVE-STUDY OF THE DEVELOPMENT OF GROWTH-HORMONE DEFICIENCY IN CHILDREN GIVEN CRANIAL IRRADIATION, AND ITS RELATION TO STATURAL GROWTH [J].
BRAUNER, R ;
RAPPAPORT, R ;
PREVOT, C ;
CZERNICHOW, P ;
ZUCKER, JM ;
BATAINI, P ;
LEMERLE, J ;
SARRAZIN, D ;
GUYDA, HJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :346-351
[9]   GROWTH AND GROWTH-HORMONE SECRETION AFTER BONE-MARROW TRANSPLANTATION [J].
BRAUNER, R ;
FONTOURA, M ;
ZUCKER, JM ;
DEVERGIE, A ;
SOUBERBIELLE, JC ;
PREVOTSAUCET, C ;
MICHON, J ;
GLUCKMAN, E ;
GRISCELLI, C ;
FISCHER, A ;
RAPPAPORT, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (04) :458-463
[10]   Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation [J].
Brauner, R ;
Adan, L ;
Souberbielle, JC ;
Esperou, H ;
Michon, J ;
Devergie, A ;
Gluckman, E ;
Zucker, JM .
JOURNAL OF PEDIATRICS, 1997, 130 (05) :785-792